Literature DB >> 18295049

Cystatin C: research priorities targeted to clinical decision making.

Michael G Shlipak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18295049     DOI： 10.1053/j.ajkd.2008.01.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

Review 1.  Association of cystatin C with adverse outcomes.

Authors:  Magdalena Madero; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

2.  Systematic shifts in cystatin C between 2006 and 2010.

Authors:  David M Maahs; Diana Jalal; Kim McFann; Marian Rewers; Janet K Snell-Bergeon
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

3.  Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.

Authors:  David M Maahs; Janet K Snell-Bergeon; John E Hokanson; Gregory L Kinney; Tomas Berl; Marian Rewers; Lorraine G Ogden
Journal:  Diabetes Technol Ther       Date:  2010-01       Impact factor: 6.118

4.  Estimating glomerular filtration rate in a population-based study.

Authors:  Anoop Shankar; Kristine E Lee; Barbara E K Klein; Paul Muntner; Peter C Brazy; Karen J Cruickshanks; F Javier Nieto; Lorraine G Danforth; Carla R Schubert; Michael Y Tsai; Ronald Klein
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

5.  Age and sex influence cystatin C in adolescents with and without type 1 diabetes.

Authors:  David M Maahs; Nicole Prentice; Kim McFann; Janet K Snell-Bergeon; Diana Jalal; Franziska K Bishop; Brittany Aragon; R Paul Wadwa
Journal:  Diabetes Care       Date:  2011-09-16       Impact factor: 17.152
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.